高强度运动与中等剂量他汀对高心血管代谢风险患者动脉僵硬度改善效果的网状Meta分析
该网状Meta分析纳入22项研究共1307例高心血管代谢风险患者,比较不同剂量他汀与不同强度运动对脉搏波传导速度(PWV)的影响。结果显示高强度运动与中等剂量他汀相比对照均显著降低PWV,作者认为高强度运动可作为预防心血管疾病的有效手段。
要点
- 高强度运动较对照显著降低PWV(MD -0.62,95%CI -1.20至-0.04)。
- 中等剂量他汀较对照显著降低PWV(MD -0.73,95%CI -1.30至-0.15)。
- 所有纳入研究偏倚风险高,结果需谨慎解读。
核心结论
- 在高心血管代谢风险患者中,高强度运动和中等剂量他汀均较对照显著改善动脉僵硬度,支持将高强度运动作为预防心血管疾病的有效工具。
研究设计与样本
- 系统检索MEDLINE、Embase、SPORTDiscus、Cochrane Central Register of Controlled Trials、Cochrane Database of Systematic Reviews和Web of Science自建库至2020年2月28日,并检索ClinicalTrials.gov获取未发表试验。
- 共纳入22项研究(18项随机对照试验和4项非随机实验研究),包括1307例高心血管代谢风险患者,来自亚洲3项、大洋洲2项、欧洲10项、北美5项、南美2项。
- 采用Cochrane RoB2工具评估偏倚风险,通过网络几何图评估证据强度,进行标准配对Meta分析和网状Meta分析比较干预与对照的直接和间接效应。
主要发现
- 标准配对Meta分析中,高强度运动 versus 对照的MD为-0.56(95%CI -1.01至-0.11,p=0.015),网状Meta分析中为-0.62(95%CI -1.20至-0.04,p=0.038)。
- 标准配对Meta分析中,中等剂量他汀 versus 对照的MD为-0.80(95%CI -1.59至-0.01,p=0.048),网状Meta分析中为-0.73(95%CI -1.30至-0.15,p=0.014)。
- 排除非随机实验研究后,高强度运动和中等剂量他汀 versus 对照的效应略有改变。
- 所有纳入研究的总体偏倚风险(RoB2)为高。
临床怎么用
- 临床医生在与高心血管代谢风险患者进行共享决策时,可考虑将高强度运动作为改善动脉僵硬度、预防心血管疾病的干预选择。
局限性
- 运动干预试验中患者的基线心血管代谢风险较他汀试验更健康,回归均值偏倚可能低估运动干预的效应,因此运动相较他汀的改善幅度可能更温和。
- 研究样本量小、患者群体异质、使用替代终点(PWV)且偏倚风险高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The comparative analysis of the effect of several doses of statins against different intensities of physical exercise on arterial stiffness (a measure of cardiovascular risk) could shed light for clinicians on which method is most effective in preventing cardiovascular disease (CVD) and be used to inform shared decision-making between doctors and patients. This study was aimed at analyzing the effect, in high cardiometabolic risk patients, of different statins doses and exercise intensities on arterial stiffness (a measure of cardiovascular risk) by integrating all available direct and indirect evidence in network meta-analyses. METHODS AND FINDINGS: We systematically searched MEDLINE, Embase, SPORTDiscus, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Web of Science databases from their inception to February 28, 2020; for unpublished trials, we also searched ClinicalTrials.gov. We searched for studies concerning the effect of statins or physical exercise on arterial stiffness, measured by pulse wave velocity (PWV). For methodological quality assessment, Cochrane Collaboration's tool for assessing risk of bias (RoB2) was used. A network geometry graph was used to assess the strength of the evidence. Comparative evaluation of the interventions effect was performed by conducting a standard pairwise meta-analysis and a network meta-analysis (NMA) for direct and indirect comparisons between interventions and control/nonintervention. A total of 22 studies were included in the analyses (18 randomized controlled trials (RCTs) and 4 nonrandomized experimental studies), including 1,307 patients with high cardiometabolic risk from Asia (3 studies), Oceania (2 studies), Europe (10 studies), North America (5 studies), and South America (2 studies). The overall risk of bias assessed with RoB2 was high in all included studies. For standard pairwise meta-analysis and NMA, high-intensity exercise versus control (mean difference (MD) -0.56; 95% CI: -1.01, -0.11; p = 0.015 and -0.62; 95% CI: -1.20, -0.04; p = 0.038, respectively) and moderate statin dose versus control (MD -0.80, 95% CI: -1.59, -0.01; p = 0.048 and -0.73, 95% CI: -1.30, -0.15; p = 0.014, respectively) showed significant MDs. When nonrandomized experimental studies were excluded, the effect on high-intensity exercise versus control and moderate statin dose versus was slightly modified. The main limitation of this study was that the magnitude of the effect of the exercise interventions could be underestimated due to regression toward the mean bias because the baseline cardiometabolic risk profile of patients in the physical exercise intervention trials was healthier than those in the statins ones; consequently, more modest improvements in physical exercise interventions compared to statins interventions can be expected. Additionally, we might consider as limitations the small study sizes, the heterogeneous patient groups, the focus on a proxy endpoint (PWV), and the high risk of bias. CONCLUSIONS: In this NMA, we found that although many patients could benefit from statins for reducing CVD risk, our results support that, considering the beneficial effects of high-intensity exercise on arterial stiffness, it would be worthwhile to refocus our attention on this type of exercise as an effective tool for the prevention of CVD. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42019123120.
引用
- Cavero-Redondo I, Deeks JJ, Alvarez-Bueno C, et al. Comparative effect of physical exercise versus statins on improving arterial stiffness in patients with high cardiometabolic risk: A network meta-analysis. PLoS Med. 2021. PMID: 33591983. doi:10.1371/journal.pmed.1003543
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。